AZ-4374

N/A

Report date: 2026/04/01 11:10:43
NME

Base Information

Drug NameAZ-4374
Drug Alias NameAZ-4374
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATPase family AAA domain-containing protein 2 inhibitors
TargetsATPase family AAA domain-containing protein 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Turkey
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Turkey
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A